Market Overview

From Earlier: Mizuho Securities Downgrades Myriad Genetics, Inc. to Neutral, Lowers PT to $30.00

Share:

Latest Ratings for MYGN

DateFirmActionFromTo
Nov 2016Stephens & Co.DowngradesOverweightEqual-Weight
Oct 2016BarclaysMaintainsEqual-weight
Oct 2016Ladenburg ThalmannDowngradesNeutralSell

View More Analyst Ratings for MYGN
View the Latest Analyst Ratings

Posted-In: News Downgrades Analyst Ratings

 

Related Articles (MYGN)